(Q39542918)

12 September 2017

Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells (English)

1 reference

12 September 2017

1 reference

1 reference

Anna Priebe

1

1 reference

12 September 2017

Lijun Tan

2

1 reference

12 September 2017

Heather Wahl

3

1 reference

12 September 2017

Angela Kueck

4

1 reference

12 September 2017

Gong He

5

1 reference

12 September 2017

Roland Kwok

6

1 reference

12 September 2017

Anthony Opipari

7

1 reference

12 September 2017

J Rebecca Liu

8

1 reference

12 September 2017

language of work or name

English

0 references

publication date

14 May 2011

1 reference

12 September 2017

1 reference

12 September 2017

122

1 reference

12 September 2017

2

1 reference

12 September 2017

389-395

1 reference

On the Origin of Cancer Cells

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

Why do cancers have high aerobic glycolysis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

Hypoxia, HIF1 and glucose metabolism in the solid tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

New colorimetric cytotoxicity assay for anticancer-drug screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

Akt stimulates aerobic glycolysis in cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

AMP-activated protein kinase and human cancer: cancer metabolism revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

Upstream and downstream of mTOR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.024

10.1016/J.YGYNO.2011.04.024

7 January 2021

Identifiers

DOI

1 reference

release_w47ezmhbe5hfzfpuhy6puatsaa

12 September 2017

0 references

1 reference